Stephen Wills joined Gamida Cell’s Board of Directors as a Director in 2019, and currently serves as the Chief Financial Officer, Chief Operating Officer, Treasurer and Secretary of Palatin Technologies, Inc., a publicly-traded biopharmaceutical company developing peptide therapeutics. Prior to joining Palatin, Mr. Wills served as Executive Chairman and Interim Principal Executive Officer of Derma Sciences, Inc., a provider of advanced wound care products, which has since been acquired by PSI. He was also previously the Chief Financial Officer of Derma Sciences, and served on the company’s Board of Directors. Mr. Wills currently serves as Chairman of the Board of Directors of MediWound Ltd., and on the Board of Directors of Amryt Pharma.

Mr. Wills is a certified public accountant. He holds a bachelor’s degree in accounting from West Chester University and a master’s degree in taxation from Temple University.